Tag Archives: neuronal exosomes

Woolsey Pharmaceuticals announced extended Series B financing to advance BRAVYL® for ALS. Research shows extracellular vesicles play a role in TDP-43 pathology, with BRAVYL significantly reducing aggregation and cytoplasmic redistribution, offering a potential breakthrough in ALS treatment...

Woolsey Pharmaceuticals, a clinical-stage pharmaceutical company developing BRAVYL (oral fasudil) for the treatment of Amyotrophic Lateral Sclerosis (ALS), announced that a poster by Dr. Daniel Linseman’s laboratory at the University of...